Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: An experimental study

Artificial Organs

Volumn 35, Issue 9, 2011, Pages 867-874

  Pierrakos, Charalampos N ^a   Bonios, Michael J ^a   Drakos, Stavros G ^a   Charitos, Efstratios I ^a   Tsolakis, Elias J ^a   Ntalianis, Argirios ^a   Nanas, Serafim N ^a   Charitos, Christos E ^b   Nanas, John N ^a   Terrovitis, John V ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Blood flow; Coronary circulation; Intra aortic balloon pump; Myocardial infarction; Reperfusion

Indexed keywords

ARTIFICIAL HEART; BALLOONS; BLOOD; BLOOD PRESSURE; CARDIOLOGY; HEART; HEMODYNAMICS; PUMPS; RISK ASSESSMENT;

BLOOD FLOW; CORONARY BLOOD FLOWS; CORONARY CIRCULATION; COUNTERPULSATION; IN-CONTROL; INTRA-AORTIC BALLOON PUMP; MECHANICAL; MYOCARDIAL AREAS; MYOCARDIAL INFARCTION; REPERFUSION;

BLOOD VESSELS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA BALLOON; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY REPERFUSION; COUNTERPULSATION; DISEASE SEVERITY; EXPERIMENTAL PIG; EXPERIMENTAL STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEMODYNAMIC PARAMETERS; NO REFLOW PHENOMENON; NONHUMAN; PRIORITY JOURNAL; PROCESS MODEL;

SUIDAE;

EID: 80052681503     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01241.x     Document Type: Article

References (39)

1. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
2. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-62.
3. Humphrey SM, Gavin JB, Herdson PB. The relationship of ischemic contracture of vascular reperfusion in the isolated rat heart. J Mol Cell Cardiol 1980;12:1397-406.
4. Tranum-Jensen J, Janse MJ, Fiolet WT, etal. Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart. Circ Res 1981;49:364-81.
5. Ho PC. Spontaneous slow flow in the saphenous vein graft: a relevant distinction of macrovascular endothelial dysfunction. Heart Vessels 2007;22:274-7.
6. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989;80:1846-61.
7. Rochitte CE, Lima JA, Bluemke DA, etal. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998;98:1006-14.
8. Sanborn TA, Sleeper LA, Bates ER, etal. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acutemyocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000;36:1123-9.
9. Nanas JN, Nanas SN, Kontoyannis DA, etal. Myocardial salvage by the use of reperfusion and intraaortic balloon pump: experimental study. Ann Thorac Surg 1996;61:629-34.
10. French JK, Feldman HA, Assmann SF, etal. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. Am Heart J 2003;146:804-10.
11. Schlegel JU. Demonstration of blood vessels and lymphatics with a fluorescent dye in ultraviolet light. Anat Rec 1949;105:433-43, incl 2 pl.
12. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
13. Fishbein MC, Meerbaum S, Rit J, etal. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
14. Ohman EM, Nanas J, Stomel RJ, etal. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 2005;19:33-9.
15. Smalling RW, Cassidy DB, Barrett R, etal. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model. Circulation 1992;85:1152-9.
16. Anderson RD, Ohman EM, Holmes DR Jr, etal. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997;30:708-15.
17. Barron HV, Every NR, Parsons LS, etal. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001;141:933-9.
18. Kovack PJ, Rasak MA, Bates ER, Ohman EM, Stomel RJ. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997;29:1454-8.
19. Feola M, Limet RR, Glick G. Direct and reflex vascular effects of intra-aortic balloon counterpulsation in dogs. Am J Physiol 1971;221:748-53.
20. Kloner RA, Rude RE, Carlson N, etal. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation 1980;62:945-52.
21. Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol 2000;85:B50-B60.
22. Barros LF, Coelho IJ, Petrini CA, Chagas AC, Rocha e Silva M. Myocardial reperfusion: leukocyte accumulation in the ischemic and remote non-ischemic regions. Shock 2000;13:67-71.
23. Amado LC, Kraitchman DL, Gerber BL, etal. Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol 2004;43:1291-8.
24. Ito H, Maruyama A, Iwakura K, etal. Clinical implications of the "no reflow" phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
25. Wu KC, Zerhouni EA, Judd RM, etal. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
26. Sakuma T, Sari I, Goodman CN, etal. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty. Cardiovasc Res 2005;66:552-61.
27. Cobb FR, Bache RJ, Rivas F, Greenfield JC Jr. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest 1976;57:1359-68.
28. Reffelmann T, Hale SL, Li G, Kloner RA. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2002;282:H766-72.
29. Ritter LS, McDonagh PF. Low-flow reperfusion after myocardial ischemia enhances leukocyte accumulation in coronary microcirculation. Am J Physiol 1997;273:H1154-65.
30. Nanas JN, Tsolakis E, Terrovitis JV, etal. Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs. Chest 2004;125:1492-9.
31. Bramos D, Ikonomidis I, Tsirikos N, etal. The association of coronary flow changes and inflammatory indices to ischaemia-reperfusion microvascular damage and left ventricular remodelling. Basic Res Cardiol 2008;103:345-55.
32. Antman EM, Hand M, Armstrong PW, etal. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction, writing on behalf of the 2004 Writing Committee. Circulation 2008;117:296-329.
33. Kern MJ, Aguirre F, Bach R, etal. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993;87:500-11.
34. Ishihara M, Sato H, Tateishi H, etal. Effects of intraaortic balloon pumping on coronary hemodynamics after coronary angioplasty in patients with acute myocardial infarction. Am Heart J 1992;124:1133-8.
35. Kern MJ, Aguirre FV, Tatineni S, etal. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 1993;21:359-68.
36. Zehetgruber M, Mundigler G, Christ G, etal. Relation of hemodynamic variables to augmentation of left anterior descending coronary flow by intraaortic balloon pulsation in coronary artery disease. Am J Cardiol 1997;80:951-5.
37. Kumbasar SD, Semiz E, Sancaktar O, etal. Concomitant use of intraaortic balloon counterpulsation and streptokinase in acute anterior myocardial infarction. Angiology 1999;50:465-71.
38. Kurisu S, Inoue I, Kawagoe T, etal. Effect of intraaortic balloon pumping on left ventricular function in patients with persistent ST segment elevation after revascularization for acute myocardial infarction. Circ J 2003;67:35-9.
39. Prondzinsky R, Lemm H, Swyter M, etal. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010;38:152-60.